89bio Inc. (ETNB) PT Lowered to $33 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
89bio Inc. (ETNB) PT Lowered to $29 at H.C. Wainwright
May 10, 2024 6:55 AM EDT(Updated - May 10, 2024 6:57 AM EDT)
H.C. Wainwright analyst Ed Arce lowered the price target on 89bio Inc. (NASDAQ: ETNB) to $29.00 (from $31.00) while maintaining a Buy rating.
The analyst commented: "Yesterday, 89bio announced that ENLIGHTEN-Cirrhosis, a Phase 3 trial focusing on... More
89bio Inc. (ETNB) PT Lowered to $13 at RBC Capital
May 10, 2024 6:22 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on 89bio Inc. (NASDAQ: ETNB) to $13.00 (from $14.00) while maintaining a Sector Perform rating.
The analyst comments "Ph.III MASH studies remain on track, though may be at a slightly higher than... More
